Navigation Links
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
Date:6/1/2009

NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University of California, San Diego ("UCSD"), to evaluate Raptor's proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") capsules in nephropathic cystinosis ("cystinosis"), a rare genetic lysosomal storage disease. Under Raptor's open Investigational New Drug application ("IND"), UCSD is performing the Raptor-sponsored trial at its General Clinical Research Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

The Phase 2b clinical trial will enroll up to six cystinosis patients with a history of good compliance using the currently available immediate-release form of cysteamine bitartrate, the only drug cleared for marketing by the U.S. Food and Drug Administration ("FDA") and European Medicines Agency ("EMEA") to treat cystinosis. The clinical trial will evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in patients. Data from the study are expected in the third quarter of 2009. Raptor plans to follow the Phase 2b clinical study with a pivotal, Phase 3 clinical study in cystinosis patients anticipated to commence in the fourth quarter of 2009.

DR Cysteamine is Raptor's proprietary enteric-coated micro-bead formulation of cysteamine bitartrate contained in a gelatin capsule and designed for increased absorption, less frequent dosing and improved tolerability relative to the current standard of care. Published studies have shown that fewer than 25% of patients taking immediate-release cystea
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
2. Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
3. Raptor Pharmaceuticals Closes $10 Million Private Placement
4. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
5. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
6. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
8. Raptor Pharmaceuticals Acquires Orphan Clinical Program
9. Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
10. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
11. OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 The patent ... molecular diagnostic test results. It also enables true ... the validation and reporting of high profile assays ... is a rapidly growing area of biotechnology that ... predisposition, cancer, and companion diagnostics in personalized medicine. ...
(Date:7/23/2014)... (UAE) (PRWEB) July 23, 2014 International ... recently announced that its biobanking project, Provia Laboratories ... to its growing Advisory Board. Scott Wolf , ... to have Dr. Vaught onboard with Provia’s ever-expanding Advisory ... expertise that Provia’s management team brings to this field, ...
(Date:7/23/2014)... efforts have made great strides in saving China,s endangered ... are over 65 giant panda reserves that have been ... efforts, just 1596 pandas remain in the wild. ... to save the panda by improving genetic diversity, avoid ... Just how are these high-profile programs doing so far? ...
(Date:7/23/2014)... (HZDR), the Vienna University of Technology and the ... nearly perfect semiconductor crystals into a silicon nanowire. ... very fast and multi-functional processing units can be ... The research results will be published in the ... considered the cornerstone of future chip technology, but ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4A crystal wedding in the nanocosmos 2
... NEW YORK, Sept. 8 Reportlinker.com announces that a new ... , Membrane Bioreactors , ... This report analyzes the worldwide markets for Membrane ... for Membrane Bioreactors by the following end-use segments: Municipal segment, ...
... , NEW YORK, Sept. 8 ... its catalogue. , , Nanoporous Materials ... , , This report analyzes ... report analyzes the market for Nanoporous (Microporous) Materials by the following ...
... , LONDON, Sept. 8 ... services to pharmaceutical and biotechnology companies, is pleased to announce ... office. Walter Colasante, as a Vice President, and Sophie ... and reimbursement expertise and expand its current offerings. , ...
Cached Biology Technology:Reportlinker Adds Membrane Bioreactors Report 2Reportlinker Adds Membrane Bioreactors Report 3Reportlinker Adds Membrane Bioreactors Report 4Reportlinker Adds Membrane Bioreactors Report 5Reportlinker Adds Membrane Bioreactors Report 6Reportlinker Adds Membrane Bioreactors Report 7Reportlinker Adds Membrane Bioreactors Report 8Reportlinker Adds Membrane Bioreactors Report 9Reportlinker Adds Membrane Bioreactors Report 10Reportlinker Adds Membrane Bioreactors Report 11Reportlinker Adds Membrane Bioreactors Report 12Reportlinker Adds Membrane Bioreactors Report 13Reportlinker Adds Membrane Bioreactors Report 14Reportlinker Adds Nanoporous Materials Report 2Reportlinker Adds Nanoporous Materials Report 3Reportlinker Adds Nanoporous Materials Report 4Reportlinker Adds Nanoporous Materials Report 5Reportlinker Adds Nanoporous Materials Report 6PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 2
(Date:7/24/2014)... in humans, affect the connections between nerve cells and ... an area of the brain that plays a significant ... The results of the study have been published in ... on the active communication between nerve cells, known as ... a dense network where they constantly relay signals to ...
(Date:7/24/2014)... Forest is a hotspot of biodiversity and one of ... and toads) in the world. However, current levels of ... years has been an increase in the description of ... advance of molecular techniques and availability of samples for ... of samples for molecular and morphological analysis, researchers from ...
(Date:7/24/2014)... 2014) For years, researchers and patients have hoped ... cell type in the bodycould provide insight into numerous ... progress has been hampered by the inability to transfer ... human counterparts, in part because human ESCs are "primed" ... Now Thorold Theunissen, Benjamin Powell, and Haoyi Wang, who ...
Breaking Biology News(10 mins):A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4A tiny new species of frog from Brazil with a heroic name 2Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2
... from Rice University's Center for Biological and Environmental ... are the most effective catalysts yet identified for ... and troublesome groundwater pollutants, trichloroethene or TCE. , ... the Georgia Institute of Technology, will appear next ...
... according to research published this week (24 Feb) in the ... British Antarctic Survey (BAS). , A study of George VI ... show that this currently 'healthy' ice shelf experienced an extensive ... recent years. The retreat coincided with a shift in ocean ...
... at Children's Hospital Boston and Harvard Medical School have ... virus (HIV) changes shape, triggering other changes that allow ... findings, published in the Feb. 24 issue of the ... and treatment approaches. , Researchers led by Howard Hughes ...
Cached Biology News:Tiny particles could solve billion-dollar problem 2Tiny particles could solve billion-dollar problem 3Antarctic ice shelf retreats happened before 2Elusive HIV shape change revealed; Key clue to how virus infects cells 2
... NPY Y2 Receptor antiserum This NPY ... spinal level and is currently being characerized in ... rat and mouse and appears to work better ... in rat. For full characterizarion in dorsal root ...
RECK (F-20)...
Black Polypropylene 384 Round Well Plate 70/Box...
... polyclonal to Peroxiredoxin 1 Peroxiredoxin ... whose mammalian members have been known ... and apoptosis. Many isoforms (about 50 ... amino acid sequence homology, particularly amino-terminal ...
Biology Products: